Citius Pharmaceuticals Inc (NASDAQ:CTXR) does about 2.32M shares in volume on a normal day but saw 5527770 shares change hands in the recent trading day. The company now has a market cap of 17.10M USD. Its current market price is $1.53, marking an increase of 15.04% compared to the previous close of $1.33. The 52 week high reached by this stock is $26.25 whilst the lowest price level in 52 weeks is $0.65.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 69.4% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 30, 2024 when D. Boral Capital upgraded the stock to “Buy” and issued a price target of $9.
The current price level is 51.89%, 74.62%, and -63.00% away from its SMA20, SMA50, and SMA200 respectively, with the CTXR price moving below the 50-day SMA on current market day. Citius Pharmaceuticals Inc (CTXR) stock is up 41.67% over the week and 118.57% over the past month. Its price is -90.87% year-to-date and -61.75% over the past year.
To reach the target analysts have set, the stock logically needs to grow 69.4 percent from here.
Outstanding shares total 11.17M with insiders holding 4.41% of the shares and institutional holders owning 5.74% of the company’s common stock. The company has a return on investment of -70.14% and return on equity of -60.06%. The forward price to earnings ratio is 4.10. The beta has a value of 1.05. Price to book ratio is 0.22.